NSE shareholding pattern
Zydus Lifesciences Limited shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 75.01%, FIIs 7.05%, and DIIs 11.28% of Zydus Lifesciences Limited (ZYDUSLIFE). Against the Jun 2026 pattern, FII holding is up 0.16 percentage points (6.89% → 7.05%), DII up 0.01 points (11.27% → 11.28%), and promoter holding unchanged at 75.01%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns as they are filed, 1 Oct 2026 to 21 Oct 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Zydus Lifesciences Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 75.01 | 7.05 | 11.28 | 6.66 | 2026-09-30 |
| Jun 2026 | 75.01 | 6.89 | 11.27 | 6.83 | 2026-06-30 |
| Jun 2026 | 75.01 | 6.89 | 11.18 | 6.92 | 2026-06-18 |
| Mar 2026 | 75 | 6.95 | 11.2 | 6.85 | 2026-03-31 |
| Dec 2025 | 75 | 7.06 | 11.08 | 6.86 | 2025-12-31 |
| Sep 2025 | 74.99 | 7.34 | 10.86 | 6.81 | 2025-09-30 |
| Jun 2025 | 74.99 | 7.13 | 11.09 | 6.79 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Zydus Lifesciences Limited
7 independent managers7 independent managers disclosed positions in Zydus Lifesciences Limited within the same window (Jul 11, 2026 – Oct 9, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Aarti Drugs Ltd, Aarti Pharmalabs Limited, Abbott India Limited, Acutaas Chemicals Limited, Advanced Enzyme Technologies Limited, Ajanta Pharma Limited, Akums Drugs and Pharmaceuticals Limited, Alembic Pharmaceuticals Limited
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Zydus Lifesciences Limited?
As of the Sep 2026 shareholding pattern, promoters held 75.01% of Zydus Lifesciences Limited (ZYDUSLIFE). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Zydus Lifesciences Limited?
Foreign institutional investors held 7.05% of Zydus Lifesciences Limited as of the Sep 2026 pattern, versus 6.89% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in Zydus Lifesciences Limited change in the Sep 2026 quarter?
FII holding in Zydus Lifesciences Limited was 6.89% in the Jun 2026 pattern and 7.05% in Sep 2026, a difference of 0.16 percentage points up. Promoter holding was unchanged at 75.01% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.